BioSpace News Archive

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results for the first quarter ended March 31, 2022, and provided an overview of recent operational highlights.

Athira Pharma, Inc. today announced that it is extending the length of the current open label extension (OLEX) study for its Phase 3 LIFT-AD and Phase 2 ACT-AD studies of fosgonimeton.

Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the quarter ended March 31, 2022.

Viatris Inc. (NASDAQ: VTRS), today reported strong results for the first quarter of 2022.

Ginkgo Bioworks announced today that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2022, on Monday, May 16.

BaroPace, Inc. announces the appointment of Michael Coyle to BaroPace’s Board of Directors.

Repare Therapeutics Inc. announced that members of its senior management team will participate in a fireside chat at the virtual 2022 Guggenheim Synthetic Lethality Day on Monday, May 16, 2022 at 9:00 a.m. Eastern Time.

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced its financial results for the first quarter ended March 31, 2022, and provided corporate updates.

Liminal BioSciences Inc. (NASDAQ: LMNL) (“Liminal BioSciences” or the “Company”), today announced that it plans to report its first quarter 2022 financial results after market close on May 10, 2021.

Invacare Corporation reported results for the quarter ended March 31, 2022.